us fda panel backs merck hepatitis drug
a merck &amp; co drug that boosts the chance of curing hepatitis c infection moved closer to the u.s. market on wednesday as an advisory panel unanimously recommended approval.
http://feeds.reuters.com/~r/reuters/healthnews/~3/cbmpeeeroci/us-merck-hepatitis-idustre73q7n220110427
23474
27 Apr 2011 21:52:35
reuters
health